The prognostic value of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with diabetes or prediabetes: insights from NHANES 2005–2018
Abstract Background The Stress hyperglycemia ratio (SHR) is a novel marker reflecting the true acute hyperglycemia status and is associated with clinical adverse events. The relationship between SHR and mortality in patients with diabetes or prediabetes is still unclear. This study aimed to investig...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-02-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12933-024-02172-8 |
_version_ | 1797275974415417344 |
---|---|
author | Lei Ding Hongda Zhang Cong Dai Aikai Zhang Fengyuan Yu Lijie Mi Yingjie Qi Min Tang |
author_facet | Lei Ding Hongda Zhang Cong Dai Aikai Zhang Fengyuan Yu Lijie Mi Yingjie Qi Min Tang |
author_sort | Lei Ding |
collection | DOAJ |
description | Abstract Background The Stress hyperglycemia ratio (SHR) is a novel marker reflecting the true acute hyperglycemia status and is associated with clinical adverse events. The relationship between SHR and mortality in patients with diabetes or prediabetes is still unclear. This study aimed to investigate the predictive value of the SHR for all-cause and cardiovascular mortality in patients with diabetes or prediabetes. Methods This study included 11,160 patients diagnosed with diabetes or prediabetes from the National Health and Nutrition Examination Survey (2005–2018). The study endpoints were all-cause and cardiovascular mortality, and morality data were extracted from the National Death Index (NDI) up to December 31, 2019. Patients were divided into SHR quartiles. Cox proportion hazards regression was applied to determine the prognostic value of SHR. Model 1 was not adjusted for any covariates. Model 2 was adjusted for age, sex, and race. Model 3 was adjusted for age, sex, race, BMI, smoking status, alcohol use, hypertension, CHD, CKD, anemia, and TG. Results During a mean follow-up of 84.9 months, a total of 1538 all-cause deaths and 410 cardiovascular deaths were recorded. Kaplan-Meier survival analysis showed the lowest all-cause mortality incidence was in quartile 3 (P < 0.001). Multivariate Cox regression analyses indicated that, compared to the 1st quartile, the 4th quartile was associated with higher all-cause mortality (model 1: HR = 0.89, 95% CI 0.74–10.7, P = 0.226; model 2: HR = 1.24, 95% CI 1.03-1.49, P = 0.026; model 3: HR = 1.30, 95% CI 1.08–1.57, P = 0.006). The 3rd quartile was associated with lower cardiovascular mortality than quartile 1 (model 1: HR = 0.47, 95% CI 0.32–0.69, P < 0.001; model 2: HR = 0.66, 95% CI 0.45–0.96, P = 0.032; model 3: HR = 0.68, 95% CI 0.46–0.99, P = 0.049). There was a U-shaped association between SHR and all-cause mortality and an L-shaped association between SHR and cardiovascular mortality, with inflection points of SHR for poor prognosis of 0.87 and 0.93, respectively. Conclusion SHR is related to all-cause and cardiovascular mortality in patients with diabetes or prediabetes. SHR may have predictive value in those patients. |
first_indexed | 2024-03-07T15:21:44Z |
format | Article |
id | doaj.art-42d5649a30d746f1909dcca3437d8dc5 |
institution | Directory Open Access Journal |
issn | 1475-2840 |
language | English |
last_indexed | 2024-03-07T15:21:44Z |
publishDate | 2024-02-01 |
publisher | BMC |
record_format | Article |
series | Cardiovascular Diabetology |
spelling | doaj.art-42d5649a30d746f1909dcca3437d8dc52024-03-05T17:36:27ZengBMCCardiovascular Diabetology1475-28402024-02-0123111110.1186/s12933-024-02172-8The prognostic value of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with diabetes or prediabetes: insights from NHANES 2005–2018Lei Ding0Hongda Zhang1Cong Dai2Aikai Zhang3Fengyuan Yu4Lijie Mi5Yingjie Qi6Min Tang7Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Cardiovascular Institute, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical CollegeDepartment of Cardiology, State Key Laboratory of Cardiovascular Disease, Cardiovascular Institute, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical CollegeDepartment of Health Policy and Management, School of Public Health, Peking University Health Science CenterDepartment of Cardiology, State Key Laboratory of Cardiovascular Disease, Cardiovascular Institute, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical CollegeDepartment of Cardiology, State Key Laboratory of Cardiovascular Disease, Cardiovascular Institute, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical CollegeDepartment of Cardiology, State Key Laboratory of Cardiovascular Disease, Cardiovascular Institute, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical CollegeDepartment of Cardiology, State Key Laboratory of Cardiovascular Disease, Cardiovascular Institute, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical CollegeDepartment of Cardiology, State Key Laboratory of Cardiovascular Disease, Cardiovascular Institute, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical CollegeAbstract Background The Stress hyperglycemia ratio (SHR) is a novel marker reflecting the true acute hyperglycemia status and is associated with clinical adverse events. The relationship between SHR and mortality in patients with diabetes or prediabetes is still unclear. This study aimed to investigate the predictive value of the SHR for all-cause and cardiovascular mortality in patients with diabetes or prediabetes. Methods This study included 11,160 patients diagnosed with diabetes or prediabetes from the National Health and Nutrition Examination Survey (2005–2018). The study endpoints were all-cause and cardiovascular mortality, and morality data were extracted from the National Death Index (NDI) up to December 31, 2019. Patients were divided into SHR quartiles. Cox proportion hazards regression was applied to determine the prognostic value of SHR. Model 1 was not adjusted for any covariates. Model 2 was adjusted for age, sex, and race. Model 3 was adjusted for age, sex, race, BMI, smoking status, alcohol use, hypertension, CHD, CKD, anemia, and TG. Results During a mean follow-up of 84.9 months, a total of 1538 all-cause deaths and 410 cardiovascular deaths were recorded. Kaplan-Meier survival analysis showed the lowest all-cause mortality incidence was in quartile 3 (P < 0.001). Multivariate Cox regression analyses indicated that, compared to the 1st quartile, the 4th quartile was associated with higher all-cause mortality (model 1: HR = 0.89, 95% CI 0.74–10.7, P = 0.226; model 2: HR = 1.24, 95% CI 1.03-1.49, P = 0.026; model 3: HR = 1.30, 95% CI 1.08–1.57, P = 0.006). The 3rd quartile was associated with lower cardiovascular mortality than quartile 1 (model 1: HR = 0.47, 95% CI 0.32–0.69, P < 0.001; model 2: HR = 0.66, 95% CI 0.45–0.96, P = 0.032; model 3: HR = 0.68, 95% CI 0.46–0.99, P = 0.049). There was a U-shaped association between SHR and all-cause mortality and an L-shaped association between SHR and cardiovascular mortality, with inflection points of SHR for poor prognosis of 0.87 and 0.93, respectively. Conclusion SHR is related to all-cause and cardiovascular mortality in patients with diabetes or prediabetes. SHR may have predictive value in those patients.https://doi.org/10.1186/s12933-024-02172-8Stress hyperglycemia ratio (SHR)All-cause mortalityCardiovascular mortalityDiabetesPrediabetes |
spellingShingle | Lei Ding Hongda Zhang Cong Dai Aikai Zhang Fengyuan Yu Lijie Mi Yingjie Qi Min Tang The prognostic value of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with diabetes or prediabetes: insights from NHANES 2005–2018 Cardiovascular Diabetology Stress hyperglycemia ratio (SHR) All-cause mortality Cardiovascular mortality Diabetes Prediabetes |
title | The prognostic value of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with diabetes or prediabetes: insights from NHANES 2005–2018 |
title_full | The prognostic value of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with diabetes or prediabetes: insights from NHANES 2005–2018 |
title_fullStr | The prognostic value of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with diabetes or prediabetes: insights from NHANES 2005–2018 |
title_full_unstemmed | The prognostic value of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with diabetes or prediabetes: insights from NHANES 2005–2018 |
title_short | The prognostic value of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with diabetes or prediabetes: insights from NHANES 2005–2018 |
title_sort | prognostic value of the stress hyperglycemia ratio for all cause and cardiovascular mortality in patients with diabetes or prediabetes insights from nhanes 2005 2018 |
topic | Stress hyperglycemia ratio (SHR) All-cause mortality Cardiovascular mortality Diabetes Prediabetes |
url | https://doi.org/10.1186/s12933-024-02172-8 |
work_keys_str_mv | AT leiding theprognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018 AT hongdazhang theprognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018 AT congdai theprognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018 AT aikaizhang theprognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018 AT fengyuanyu theprognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018 AT lijiemi theprognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018 AT yingjieqi theprognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018 AT mintang theprognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018 AT leiding prognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018 AT hongdazhang prognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018 AT congdai prognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018 AT aikaizhang prognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018 AT fengyuanyu prognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018 AT lijiemi prognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018 AT yingjieqi prognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018 AT mintang prognosticvalueofthestresshyperglycemiaratioforallcauseandcardiovascularmortalityinpatientswithdiabetesorprediabetesinsightsfromnhanes20052018 |